Allspring Global Investments
GTHX

Allspring Global Investments’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Allspring Global Investments’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-31,443
Closed -$78.3K – 2919
2023
Q2 		$78.3K Buy
+31,443
New +$85.9K ﹤0.01% 2145
2022
Q2 		– Sell
-15,374
Closed -$116K – 2988
2022
Q1 		$116K Sell
15,374
-4,038
-21% -$38.3K ﹤0.01% 2722
2021
Q4 		$198K Buy
+19,412
New +$247K ﹤0.01% 2637

Other funds holding GTHX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Allspring Global Investments's GTHX Position: Q3 2023 in Review

Allspring Global Investments sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2023, closing a stake of 31,443 shares — an estimated $78.3K sold.

Allspring Global Investments first reported a position in GTHX in Q4 2021 and held it in 3 quarters. The position peaked at $198K in Q4 2021. 72 funds tracked by Wall St. Rank hold GTHX as of Q3 2023.

  • Allspring Global Investments reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Allspring Global Investments sold 31,443 G1 Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $78.3K.
  • Allspring Global Investments first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Allspring Global Investments's G1 Therapeutics, Inc. Common Stock position peaked at $198K in Q4 2021.
  • 72 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Allspring Global Investments's 13F filing for Q3 2023, filed 27 Oct 2023.